ANXA5 and pulmonary arterial hypertension: This study demonstrated that all single-labeled LEVs, PEVs, REVs, EEVs and Annexin V+ EVs, as well as dual-labeled Annexin V+ REVs were significantly increased in SLE-PAH patients compared to SLE-non-PAH patients.